NEW YORK, March 16 Reportlinker.com announces that a new market research report is available in its catalogue:
Lyme Disease - Drug Pipeline Analysis and Market Forecasts to 2016
Advertisement
http://www.reportlinker.com/p0182976/Lyme-Disease---Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016.html
Description
Lyme Disease - Drug Pipeline Analysis and Market Forecasts to 2016
Advertisement
Summary
"Lyme Disease - Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global Lyme disease market. The report identifies the key trends shaping and driving the global Lyme disease market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global Lyme disease sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.
Scope
The Scope of the report includes:
- Annualized global Lyme disease market revenues data from 2001 to 2009, forecast forward for 7 years to 2016.
- Geographic markets covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
- Analysis of the current and future market competition in the global Lyme disease market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for the future market associated with Lyme disease
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Lyme disease market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global Lyme disease market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What's the next big thing in the global Lyme disease market landscape? - Identify, understand and capitalize.
Companies Mentioned
Intercell AG
Baxter International Inc
Table of Contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Lyme Disease Market : Market Characterization 6
2.1 Disease Overview 6
2.2 Symptoms 6
2.3 Diagnosis 6
2.4 Treatment 7
2.5 Epidemiology 8
2.6 Prevention 9
2.7 Lyme Disease Market Size 10
2.8 Lyme Disease Market Forecast and CAGR 10
2.9 Drivers and Barriers for the Lyme Disease Market 11
2.9.1 Drivers for the Lyme Disease Market 11
2.9.2 Barriers for the Lyme Disease Market 12
2.10 Opportunity and Unmet Need 12
2.11 Key Takeaway 13
3 Lyme Disease Market : Competitive Assessment 14
3.1 Overview 14
3.2 Strategic Competitor Assessment 14
3.3 Product Profile for the Major Off-Label Marketed Products in the Lyme Disease Market 15
3.3.1 Doxycycline 15
3.3.2 Cefuroxime Axetil 15
3.3.3 Amoxicillin 16
3.3.4 Erythromycin (Macrolides) 17
3.3.5 Ceftriaxone 18
3.3.6 Penicillin G 18
3.4 Key Takeaway 20
4 Lyme Disease Market : Pipeline Assessment 21
4.1 Overview 21
4.2 Strategic Pipeline Assessment 21
4.2.1 Technology Trends Analytic Framework 21
4.3 Lyme Disease Therapeutics - Promising Drugs under Clinical Development 23
4.4 Molecule Profile for Promising Drugs under Clinical Development 23
4.4.1 Lyme Borreliosis Vaccine 23
4.4.2 OspA Chimaeric Vaccine 23
4.4.3 DbpA + OspA 24
4.5 Lyme Disease Market - Clinical Pipeline by Mechanism of Action 24
4.6 Lyme Disease - Pipeline by Clinical Phases of Development 25
4.6.1 Lyme Disease Therapeutics - Phase III Clinical Pipeline 25
4.6.2 Lyme Disease Therapeutics - Phase II Clinical Pipeline 25
4.6.3 Lyme Disease Therapeutics - Preclinical Pipeline 25
4.7 Discontinued Drug for Lyme Disease 26
4.7.1 LYMErix 26
4.8 Key Takeaway 26
5 Lyme Disease Market : Implications for Future Market Competition 27
6 Lyme Disease Market : Future Players in the Lyme Disease Market 29
6.1 Introduction 29
6.2 Intercell AG 29
6.2.1 Company Overview 29
6.2.2 Financial Performance 29
6.2.3 Business Description 29
6.2.4 Vaccine Portfolio 30
6.3 Baxter International Inc 31
6.3.1 Company Overview 31
6.3.2 Financial Performance 31
6.3.3 Business Description 31
6.3.4 Vaccine Portfolio 31
7 Lyme Disease Market : Appendix 32
7.1 Market Definitions 32
7.2 Abbreviations 32
7.3 Research Methodology 33
7.3.1 Coverage 34
7.3.2 Secondary Research 34
7.3.3 Forecasting 34
7.3.4 Primary Research 36
7.3.5 Expert Panels 37
7.4 Contact Us 37
7.5 Disclaimer 37
7.6 Sources 37
List of Tables
1.1 List of Tables
Table 1: Lyme Disease Recommended Antibiotics and Doses, 2010 7
Table 2: Lyme Disease Reported Cases in Top 10 States of America During 1999 to 2008 9
Table 3: Global Lyme Disease Therapeutics Market, Revenue ($m), 2001-2009 11
Table 4: Global Lyme Disease Therapeutics Market, Revenue ($m), 2009-2016 11
Table 5: Clinical Effectiveness of Ceftin Tablets Compared to Doxycycline, 2010 16
Table 6: Major Off Label Marketed Products Comparison in Lyme Disease Market, 2010 19
Table 7: Lyme Disease Therapeutics - Most Promising Drugs Under Clinical Development, 2010 23
Table 8: Lyme Disease Therapeutics - Phase III Clinical Pipeline, 2010 25
Table 9: Lyme Disease Therapeutics - Phase II Clinical Pipeline, 2010 25
Table 10: Lyme Disease Therapeutics - Preclinical Pipeline, 2010 25
Table 11: Intercell AG - Marketed Vaccines, 2010 30
Table 12: Intercell AG - Pipeline Products, 2010 30
Table 13: Baxter Vaccine- Pipeline Products, 2010 31
List of Figures
1.2 List of Figures
Figure 1: Lyme Disease Reported Cases In Top 10 States of America, 2010 9
Figure 2: Global Lyme Disease Therapeutics Market Revenue ($m) 2001-2009 10
Figure 3: Global Lyme Disease Therapeutics Market Revenue ($m) 2009-2016 11
Figure 4: Opportunity and Unmet Need in the Lyme Disease Market, 2010 13
Figure 5: Strategic Competitor Assessment of the Major Off-Label Products for Lyme Disease, 2010 14
Figure 6: Technology Trends Analytic Framework of the Lyme Disease Pipeline, 2010 22
Figure 7: Technology Trends Analytic Framework of the Lyme Disease Pipeline - Description, 2010 22
Figure 8: Lyme Disease Market - Clinical Pipeline by Mechanism of Action, 2010 24
Figure 9: Lyme Disease Pipeline by Phase of Clinical Development, 2010 25
Figure 10: Implications for Future Market Competition in the Lyme Disease Market, 2010 27
Figure 11: Lyme Disease Market - Clinical Pipeline by Company, 2010 29
Figure 12: GlobalData Methodology 33
Figure 13: GlobalData Market Forecasting Model 36
To order this report:
Pharmaceutical Industry: Lyme Disease - Drug Pipeline Analysis and Market Forecasts to 2016
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg Reportlinker Email: [email protected] US: (805)652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker
